abstract |
The present invention provides MDM2 inhibitor compounds of Formula I, n n n n n n n n n n n n wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor. |